Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|June 1, 1994
Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumoursF V Cromme, P F van Bommel, J M Walboomers, et al.
British Journal of Cancer|March 1, 2003
Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasiaE J Davidson, L S Morris, I S Scott, et al.
Vaccine|July 13, 2004
Effect of TA-CIN (HPV 16 L2E6E7) booster immunisation in vulval intraepithelial neoplasia patients previously vaccinated with TA-HPV (vaccinia virus encoding HPV 16/18 E6E7)E J Davidson, R L Faulkner, P Sehr, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|August 1, 1996
Immunogenetic factors in HPV-associated cervical cancer: influence on disease progressionM F Duggan-Keen, P J Keating, F R Stevens, et al.
Leukemia|January 24, 2012
5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotypeF V Castro, O J McGinn, S Krishnan, et al.
Tissue Antigens|July 8, 2000
Multiple mechanisms underlie HLA dysregulation in cervical cancerC S Brady, J S Bartholomew, D J Burt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patientsW M Mulder, P L Stern, M J Stukart, et al.
Cancer Research|May 1, 1998
Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal studyT D de Gruijl, H J Bontkes, J M Walboomers, et al.
The Journal of General Virology|March 12, 1999
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcomeT D de Gruijl, H J Bontkes, J M Walboomers, et al.
International Journal of Cancer|August 30, 2000
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasiaH J Bontkes, T D de Gruijl, A J van den Muysenberg, et al.
Pageof 10